| Prev Close | 15.05 |
| Open | 15.05 |
| Day Low/High | 14.85 / 15.10 |
| 52 Wk Low/High | 6.08 / 11.89 |
| Volume | 29.12K |
| Avg Volume | 69.90K |
| Exchange | NASDAQ |
| Shares Outstanding | 17.25M |
| Market Cap | 260.40M |
| EPS | 0.30 |
| P/E Ratio | 47.19 |
| Div & Yield | 0.20 (1.30%) |
DILIsym Services Inc., a Simulations Plus company (NASDAQ: SLP) and a leading provider of simulation and modeling software for pharmaceutical safety and efficacy, today announced that it has released Version 6A of its...
Looking at the universe of stocks we cover at Dividend Channel, on 7/26/17, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.05, payable on 8/4/17.
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, today announced that its board of...
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical...
Simulations Plus, Inc. (Nasdaq:SLP) announced today that it expects to file its quarterly report on Form 10-Q for the third quarter of its 2017 fiscal year, the period ended May 31, 2017, on Monday, July 10, 2017.
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the third quarter of its fiscal year 2017,...
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that the Stock Purchase Agreement (the "Agreement") with DILIsym...
Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, announced that it will be presenting at the 7 th Annual LD...
Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical...
Looking at the universe of stocks we cover at Dividend Channel, on 5/4/17, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.05, payable on 5/15/17.
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it has entered into a Stock Purchase Agreement (the...
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that Dr.
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, today announced that its board of...
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has signed a...
Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for all phases of pharmaceutical discovery and development from the earliest discovery through all...
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling & simulation solutions for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has entered into a distributor...
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling & simulation solutions for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has released version 9.
Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the second quarter of its 2017 fiscal year on Monday, April 10, 2017.
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the second quarter of its fiscal year 2017,...
Looking at the universe of stocks we cover at Dividend Channel, on 1/26/17, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.05, payable on 2/6/17.
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly...
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that it has released Version 8.
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all stages of pharmaceutical discovery and development from the earliest discovery through all...
Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the first quarter of its 2017 fiscal year on Monday, January 9, 2017.
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the first quarter of its fiscal year 2017,...
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2016 fiscal year (FY16) and fourth quarter (4Q16) ended August...
Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file Form 10-K for the 2016 fiscal year ended August 31, 2016, with the U.
